GoodRx Holdings, Inc. (GDRX)
| Market Cap | 1.53B |
| Revenue (ttm) | 799.87M |
| Net Income (ttm) | 34.60M |
| Shares Out | 347.45M |
| EPS (ttm) | 0.09 |
| PE Ratio | 49.33 |
| Forward PE | 27.67 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 5,567,136 |
| Open | 4.704 |
| Previous Close | 4.670 |
| Day's Range | 4.281 - 4.704 |
| 52-Week Range | 3.305 - 8.800 |
| Beta | 1.24 |
| Analysts | Buy |
| Price Target | 6.33 (+43.86%) |
| Earnings Date | Aug 6, 2025 |
About GDRX
GoodRx Holdings, Inc., together with its subsidiaries, offers information and tools that enable consumers to compare prices and save on their prescription drug purchases in the United States. The company operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and access to negotiated prices. It also offers other healthcare products and services, including subscriptions and pharma manufacturer solutions, as well as telehealth services through the GoodRx Care platform. In addition, ... [Read more]
Financial Performance
Financial StatementsAnalyst Summary
According to 9 analysts, the average rating for GDRX stock is "Buy." The 12-month stock price target is $6.33, which is an increase of 43.86% from the latest price.
News
Is Novo Nordisk deal the much-needed catalyst for Goodrx stock?
Goodrx Holdings Inc (NASDAQ: GDRX) closed roughly 50% higher on August 18th after Bagsværd-headquartered Novo Nordisk (NYSE: NVO) announced a GLP-1 partnership with the healthcare platform. According ...
GoodRx: After A 30% Surge On The Novo News, Is The Story Just Beginning?
GoodRx Holdings, Inc.'s partnership with Novo Nordisk highlights its vital role in direct-to-consumer drug pricing, driving a 30% stock surge and validating its business model. Pharma Manufacturer Sol...
Why is GDRX stock up 30% today? GoodRx strikes deal to sell Ozempic and Wegovy after Novo Nordisk's breakup with Hims
Share prices of GoodRx (NASDAQ: GDRX), the American healthcare company and telemedicine service, are currently soaring after the company announced that it will partner with Novo Nordisk to offer the l...
Novo Cuts Price of Ozempic in Half for Cash Buyers
Novo Nordisk A/S is slashing the cost of Ozempic for cash-paying patients to $499 a month through NovoCare and partnering with GoodRx Holdings Inc. to offer it at the same price at US pharmacies. Bloo...
GoodRx Stock Spikes 35% on Novo Nordisk Collaboration. They're Offering Ozempic for $499 a Month.
GoodRx announces a collaboration with Novo Nordisk to make Ozempic cheaper for self-paying patients.
GoodRx Announces Collaboration with Novo Nordisk to Expand Access to Ozempic® and Wegovy® for $499-Per-Month
SANTA MONICA, Calif.--(BUSINESS WIRE)--GoodRx (Nasdaq: GDRX), the leading platform for medication savings in the U.S., today announced that via a collaboration with Novo Nordisk, all strengths of Ozem...
GoodRx Holdings, Inc. (GDRX) Q2 2025 Earnings Call Transcript
GoodRx Holdings, Inc. (NASDAQ:GDRX) Q2 2025 Earnings Call August 7, 2025 8:00 AM ET Company Participants Aubrey Reynolds - Director of Investor Relations Christopher A. McGinnis - CFO & Treasurer Wen...
GoodRx Reports Second Quarter 2025 Results
SANTA MONICA, Calif.--(BUSINESS WIRE)--GoodRx Holdings, Inc. (Nasdaq: GDRX) ("we," "us," "our," “GoodRx,” or the “Company”), the leading platform for medication savings in the U.S., has released its f...
GoodRx Appoints Amazon Pharmacy Veteran Laura Jensen as President of Pharma Solutions
SANTA MONICA, Calif.--(BUSINESS WIRE)--GoodRx (Nasdaq: GDRX), the leading platform for medication savings in the U.S., today announced the appointment of Laura Jensen as Chief Commercial Officer and P...
GoodRx Announces Date for Second Quarter 2025 Earnings Release and Conference Call
SANTA MONICA, Calif.--(BUSINESS WIRE)--GoodRx Holdings, Inc. (Nasdaq: GDRX) (“GoodRx” or the “Company”), the leading platform for medication savings in the U.S., today announced it will release its se...
GoodRx: A One Big Beautiful Bill Act Beneficiary
GoodRx connects uninsured and underinsured consumers with prescription discounts, acting as a broker between consumers, PBMs, and pharmacies. Recent OBBBA legislation will significantly cut Medicaid s...
GoodRx Launches New Erectile Dysfunction Subscription Service to Simplify Access and Eliminate Treatment Barriers
SANTA MONICA, Calif.--(BUSINESS WIRE)--GoodRx (Nasdaq: GDRX), the leading platform for medication savings in the U.S., today announced the launch of a new subscription service for erectile dysfunction...
GoodRx Launches Community Link to Offer Independent Pharmacies Cost-Plus Pricing
SANTA MONICA, Calif.--(BUSINESS WIRE)--GoodRx (Nasdaq: GDRX), the leading platform for medication savings in the U.S., today announced the launch of GoodRx Community Link. Designed to address the indu...
GoodRx: Stabilizing Revenue Amid Healthy Profit Gains
I'm reiterating my Buy rating on GoodRx, as its valuation is compelling and the business is showing signs of stabilization under new leadership. GoodRx's recurring revenue base, expanding pharma partn...
GoodRx Open Sources Lifecycle to Support Innovation in Software Development Velocity and Developer Productivity
SANTA MONICA, Calif.--(BUSINESS WIRE)--GoodRx (Nasdaq: GDRX), the leading platform for medication savings in the U.S., today announced it is open-sourcing Lifecycle, a homegrown development tool desig...
GoodRx to Launch Direct Contracting for Independent Community Pharmacies
SANTA MONICA, Calif.--(BUSINESS WIRE)--GoodRx (Nasdaq: GDRX), the leading platform for medication savings in the U.S., today announced that it will launch a new offering for independent community phar...
GoodRx Offers Value Proposition As Pharmacy Costs Shifts To Consumers: Analyst
JP Morgan analyst Lisa C. Gill revised her 2025 outlook on GoodRx Holdings GDRX following the company's first-quarter earnings.
GoodRx Holdings, Inc. (GDRX) Q1 2025 Earnings Call Transcript
GoodRx Holdings, Inc. (NASDAQ:GDRX) Q1 2025 Earnings Conference Call May 8, 2025 8:00 AM ET Company Participants Aubrey Reynolds – Director-Investor Relations Wendy Barnes – President and Chief Execu...
GoodRx Reports First Quarter 2025 Results
SANTA MONICA, Calif.--(BUSINESS WIRE)--GoodRx Holdings, Inc. (Nasdaq: GDRX) ("we," "us," "our," “GoodRx,” or the “Company”), the leading platform for medication savings in the U.S., has released its f...
GoodRx Announces Date for First Quarter 2025 Earnings Release and Conference Call
SANTA MONICA, Calif.--(BUSINESS WIRE)--GoodRx Holdings, Inc. (Nasdaq: GDRX) (“GoodRx” or the “Company”), the leading platform for medication savings in the U.S., today announced it will release its fi...
GoodRx Launches eCommerce Offering for Retail Pharmacies
GoodRx has launched an eCommerce experience for retail pharmacies in collaboration with grocery chain Hy-Vee. With this new tool, announced Thursday (April 3), GoodRx will check inventories when a con...
GoodRx Introduces New E-commerce Experience for Retail Pharmacies
SANTA MONICA, Calif.--(BUSINESS WIRE)--GoodRx (Nasdaq: GDRX), the leading platform for medication savings in the U.S., today announced a new e-commerce experience for retail pharmacies that improves h...
GoodRx: Great Value For Patient Investors (Upgrade)
GoodRx is a great small-cap value stock to buy amid the recent downturn. I'm upgrading the stock to a buy. GoodRx showcases strong adjusted EBITDA despite slower growth, making it an attractive target...
GoodRx Appoints Aaron Crittenden as President of Rx Marketplace and Scott Pope, PharmD, as Chief Pharmacy Officer and Head of Clinical Engagement
SANTA MONICA, Calif.--(BUSINESS WIRE)--GoodRx (Nasdaq: GDRX), the leading platform for medication savings in the U.S., today announced the appointment of Aaron Crittenden as President of Rx Marketplac...
GoodRx Report Reveals Striking Gender Divide in Prescription Medication Spending
SANTA MONICA, Calif.--(BUSINESS WIRE)--GoodRx (Nasdaq: GDRX), the leading platform for medication savings in the U.S., today released a new report, The Prescription Drug Gender Divide, detailing how w...